# A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study)

> **NCT02327416** · PHASE3 · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** Y peginterferon alfa-2b
- **DRUG:** Granulocyte-macrophage colony stimulating factor
- **DRUG:** Entecavir and or adefovir dipivoxil

## Key facts

- **NCT ID:** NCT02327416
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2018-12
- **Final completion:** 2019-06
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2016-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02327416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02327416, "A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02327416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*